Publications

Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women  (2024)

Authors:
Cordioli, Maddalena; Gios, Lorenzo; Mirandola, Massimo; Zorzi, Antonella; Barbara, Christopher; Padovese, Valeska; Hancali, Amina; Oumzi, Hicham; Kularatne, Ranmini; Jiang, Ting-Ting; Caceres, Carlos F; Vargas, Silver; Alvarez, Christian S; Camey, Elsy; Peeling, Rosanna W; Unemo, Magnus; Ballard, Ron; Blondeel, Karel; Kiarie, James; Thwin, Soe Soe; Toskin, Igor
Title:
Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
Year:
2024
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
Elettronico
Referee:
No
Name of journal:
BMJ OPEN
ISSN of journal:
2044-6055
N° Volume:
14
Number or Folder:
6
Page numbers:
1-7
Keyword:
diagnostic microbiology; epidemiology; infectious diseases; public health
Short description of contents:
Introduction: In 2016, WHO estimated there were roughly 374 million new infections among adults of the following four curable sexually transmitted infections (STIs): chlamydia (caused by Chlamydia trachomatis (CT)), gonorrhoea (Neisseria gonorrhoeae (NG)), syphilis (Treponema pallidum) and trichomoniasis (Trichomonas vaginalis (TV)). Accurate point-of-care tests (POCTs) for screening of genital and extragenital CT, NG and TV infections are of great value and have been developed during recent decade. Several tests are commercially available and have shown encouraging performance compared with 'gold-standard' reference tests in laboratory-based studies. However, there is limited data on their clinical performance, including at the POC. Key populations, such as men who have sex with men (MSM), are at higher risk of these STIs at genital and extragenital sites and these STIs are often asymptomatic, especially in extragenital sites and in women. We will conduct a clinical-based evaluation to assess the performance characteristics and acceptability to end-users of molecular-based diagnostic technology for POC/near patient use of the Xpert CT/NG (Cepheid, Sunnyvale, California, USA) test for screening of genital, anorectal and pharyngeal CT and NG infections in MSM and the Xpert CT/NG and Xpert TV (Cepheid, Sunnyvale, California, USA) for screening of genital CT, NG and TV among women at risk for these STIs compared with gold-standard reference nucleic acid amplification tests. This master protocol outlines the overall research approach that will be used in seven countries. Method and analyses: Consecutive MSM and women at risk presenting at the clinical sites in high, and low- and middle-income countries will be enrolled. The POCTs to be evaluated are Xpert CT/NG and Xpert TV. All procedures will be carried out by trained healthcare staff and tests performed in strict accordance with the manufacturer's instructions. The sensitivity, specificity, positive and negative predictive values for each POCT will be calculated. The study is ongoing with recruitment expected to be completed in all countries by mid-2022 to late-2022. Ethics and dissemination: Prior to enrolment, this core protocol was independently peer-reviewed and approved by the research project review panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research and by the WHO Ethics Review Committee (ERC). The core protocol has been slightly adapted accordingly to individual countries and adaptations approved by both RP2 and ERC, as well as all relevant institutional review boards at each participating site. Results will be disseminated through peer-reviewed journals and presented at relevant national/international conferences.
Product ID:
140282
Handle IRIS:
11562/1129609
Last Modified:
October 30, 2024
Bibliographic citation:
Cordioli, Maddalena; Gios, Lorenzo; Mirandola, Massimo; Zorzi, Antonella; Barbara, Christopher; Padovese, Valeska; Hancali, Amina; Oumzi, Hicham; Kularatne, Ranmini; Jiang, Ting-Ting; Caceres, Carlos F; Vargas, Silver; Alvarez, Christian S; Camey, Elsy; Peeling, Rosanna W; Unemo, Magnus; Ballard, Ron; Blondeel, Karel; Kiarie, James; Thwin, Soe Soe; Toskin, Igor, Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women «BMJ OPEN» , vol. 14 , n. 62024pp. 1-7

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share